Modeling the Impact of Antiretroviral Use in Developing Countries 英文参考文献.docVIP

下载本文档

3
0
约1.3万字
约 2页
2017-05-12 发布于上海
举报
版权申诉

Modeling the Impact of Antiretroviral Use in Developing Countries 英文参考文献.doc

1、本文档共2页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Modeling the Impact of Antiretroviral Use in Developing Countries 英文参考文献

respPectives Modeling the Impact of Antiretroviral Use in Developing Countries Stefano M. Bertozzi, Sergio Bautista-Arredondo* I The authors’ model predicted that the unlimited provision of ART, started at late-stage infection (AIDS), would lead to an increase in HIV prevalence. The effect of additionally treating patients with earlier infection (pre- AIDS) would depend on whether treated patients changed their sexual behavior. The authors concluded that one cannot expect the provision of ART, at least in high-prevalence African epidemics, to have important effects on HIV transmission, a ?nding that is consistent with the previous studies summarized above. deally, evaluations of strategies related to the use of antiretroviral agents would use large-scale Mathematical Models of HIV Treatment ART (for example, initiating treatment at varying stages of disease). Mathematical models have been used to assess the impact of antiretroviral programs on HIV transmission [6]. Even though there is no consensus on the direction of the effect, many of these studies have predicted that provision of antiretroviral therapy (ART) could have a striking effect on transmission when coverage is high [7– 10]. However, these studies also suggest that the potential impact of drug- induced biological changes (reduced infectivity or increased duration of infection) on HIV transmission is likely to be minor compared with the randomized trials with HIV-related mortality as the primary endpoint. In reality, however, such studies are rarely conducted, given the long follow-up needed and the substantial costs. Furthermore, people currently living with HIV/AIDS need treatment now, not at the conclusion of long-term prospective trials. Model-based methods are a powerful and practical means of performing formal comparisons of health interventions when the ideal is not possible. Model-based analyses synthesize data from multiple sources, permitting decision makers to understand the likely impact of